The trial achieved its primary endpoint, as previously revealed at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting.
Islatravir, Merck’s investigational nucleoside reverse transcriptase translocation inhibitor (NRTTI), inhibits HIV-1 replication through a variety of mechanisms
The current inactivated polio vaccine (IPV), which uses a destroyed form of the poliovirus to trigger an immune system response
At the time of the analysis, less than 25% of the necessary number of events had taken place, indicating that overall survival was not mature.
CagriSema showed a statistically significant and superior weight loss at week 68 compared to placebo, meeting the trial’s primary aim.
The Phase 3 VENTURA research study, which was assessing aticaprant as an adjunctive treatment for major depressive disorder (aMDD), has been discontinued by Johnson & [Read More…]
The study merely demonstrates a connection rather than proving that painkillers enhance concussion recovery.
In a randomized phase III study, Gazyva®/Gazyvaro® is the only anti-CD20 monoclonal antibody that shows a full renal response benefit.
GUB014295 is a calcitonin and amylin receptor-specific agonist that may be a long-acting amylin analog.
Two blockbuster weight loss drugs including Lilly’s Zepbound were in U.S. FDA’s drugs shortage list.
